ReviewAdvances in experimental medicine and biology2026
Multi-omics Data Integration.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human diseases are multi-factorial, affecting multiple aspects of a homeostatic system. Recent advances in high-throughput technology have allowed the generation of various omics datasets from large cohorts at affordable costs and hence made it possible to study the complex dynamical systems perturbed in human diseases. Studying the complex perturbed systems offers a mechanistic understanding to identify druggable targets and offers new avenues for individualised medical intervention. Mechanisms driving complex human diseases cannot be explored merely by single omics-focused studies. In addition, the heterogeneity among the human populations adds additional complexity and limits the possibility for inferring the regulatory mechanisms underlying these diseases. Examining the disease or phenotype of interest through the lens of multiple omics layers may allow the dissection of the perturbed biological processes associated with the disease. Studying a complex disease through multiple omics layers providing vast information is quite a challenging task and, therefore, requires statistical frameworks to achieve integrative multi-omics analysis. In this chapter, we first summarise key characteristics of each of the omics layers and the various considerations important for the implementation of statistical methods. We then shed light on the most common statistical methods used for multi-omics integration studies and highlight various published examples showing the use of these methods for addressing key biological questions. For this, we show integration examples focused on at least two prime omics layers. We next focus on methods and examples showing multi-omics integration to study dynamical systems in large cohort studies. Finally, we discuss some of the multi-omics approaches and examples from single-cell multi-omics datasets.
Indexed as
Identifiers
42071151What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.